missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LSD Polyclonal Antibody

Description
Working Concentration: 0.625 μg/mL. Sensitivity: 1 ng/mL LSD produces 82% inhibition in a competitive ELISA employing Lysergic Acid Diethylamide (LSD) polyclonal antibody.
LSD is a semisynthetic derivative of ergot (Claviceps purpurea). Lysergide has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood. [National Center for Biotechnology Information. PubChem Compound Database; CID=5761].
Specifications
Specifications
| Antigen | LSD |
| Applications | ELISA |
| Classification | Polyclonal |
| Concentration | 0.625 μg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.4 |
| Gene Alias | C20H25N3O; lysergic acid diethylamide |
| Host Species | Sheep |
| Immunogen | LSD(1)-BSA. |
| Purification Method | Purified |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?